# CIViC

Source: https://onco.cc/collections/civic/  
OnCo record `civic` (Collection). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

CIViC is an open, Wikipedia-style database of what cancer mutations mean for treatment.

## Summary

CIViC holds community-curated clinical interpretations of variants in cancer, in an open, Wikipedia-style model where each evidence item is linked to the publication it came from. It is run by Washington University in St Louis through the Siteman Cancer Center, released under CC0, and both the code and the data are open. CIViC was a founding member of the GA4GH VICC meta-knowledgebase. On OnCo it appears alongside Cancer variant knowledgebases and molecular tumour boards and Clinical NGS bioinformatics and variant interpretation, and it is cited by the bottleneck Knowledge reaches practice too slowly and by ideas including Every tumour genomic report machine-readable and deposited nationally and An open knowledge graph linking trials, results, biomarkers, drugs and recommendations.

## Fields

- Kind: Collection
- Last checked: 2026-09-04
- URL: https://civicdb.org
- Holds: Community-curated clinical interpretations of variants in cancer.
- Licence: CC0

## Sources

- CIViC: https://civicdb.org

## Connected records

- technologies: [Cancer variant knowledgebases and molecular tumour boards](https://onco.cc/technologies/variant-knowledgebases/), [Clinical NGS bioinformatics and variant interpretation](https://onco.cc/technologies/ngs-bioinformatics-software/)
- targets: [ABCB1](https://onco.cc/targets/abcb1/), [ABCC10](https://onco.cc/targets/abcc10/), [ABCC3](https://onco.cc/targets/abcc3/), [ABCG2](https://onco.cc/targets/abcg2/), [ABL2](https://onco.cc/targets/abl2/), [ACTA1](https://onco.cc/targets/acta1/), [ACTB](https://onco.cc/targets/actb/), [ACTL6A](https://onco.cc/targets/actl6a/), [AEBP1](https://onco.cc/targets/aebp1/), [AGR2](https://onco.cc/targets/agr2/), [AIMP2](https://onco.cc/targets/aimp2/), [ALCAM](https://onco.cc/targets/alcam/), [ALDH1A2](https://onco.cc/targets/aldh1a2/), [APC](https://onco.cc/targets/apc/), [ARAF](https://onco.cc/targets/araf/), [AREG](https://onco.cc/targets/areg/), [ARHGAP35](https://onco.cc/targets/arhgap35/), [ARID1A](https://onco.cc/targets/arid1a/), [ARID1B](https://onco.cc/targets/arid1b/), [ARID2](https://onco.cc/targets/arid2/), [ASCL1](https://onco.cc/targets/ascl1/), [ASNS](https://onco.cc/targets/asns/), [ASS1](https://onco.cc/targets/ass1/), [ASXL1](https://onco.cc/targets/asxl1/), [ATG12](https://onco.cc/targets/atg12/), [ATG7](https://onco.cc/targets/atg7/), [ATM](https://onco.cc/targets/atm/), [ATP7B](https://onco.cc/targets/atp7b/), [ATRX](https://onco.cc/targets/atrx/), [ATXN1L](https://onco.cc/targets/atxn1l/), [ATXN7](https://onco.cc/targets/atxn7/), [AURKA](https://onco.cc/targets/aurka/), [AURKB](https://onco.cc/targets/aurkb/), [AXIN2](https://onco.cc/targets/axin2/), [B2M](https://onco.cc/targets/b2m/), [B4GALT1](https://onco.cc/targets/b4galt1/), [BACH2](https://onco.cc/targets/bach2/), [BAP1](https://onco.cc/targets/bap1/), [BARD1](https://onco.cc/targets/bard1/), [BCL10](https://onco.cc/targets/bcl10/), [BCL11A](https://onco.cc/targets/bcl11a/), [BCL6](https://onco.cc/targets/bcl6/), [BCL7A](https://onco.cc/targets/bcl7a/), [BCOR](https://onco.cc/targets/bcor/), [BIRC3](https://onco.cc/targets/birc3/), [BIRC5](https://onco.cc/targets/birc5/), [BIRC6](https://onco.cc/targets/birc6/), [BIRC7](https://onco.cc/targets/birc7/), [BLK](https://onco.cc/targets/blk/), [BMP7](https://onco.cc/targets/bmp7/), [BRIP1](https://onco.cc/targets/brip1/), [BTG1](https://onco.cc/targets/btg1/), [BTG2](https://onco.cc/targets/btg2/), [CALR](https://onco.cc/targets/calr/), [CARD11](https://onco.cc/targets/card11/), [CASP8](https://onco.cc/targets/casp8/), [CBL](https://onco.cc/targets/cbl/), [CBLB](https://onco.cc/targets/cblb/), [CBLC](https://onco.cc/targets/cblc/), [CCN2](https://onco.cc/targets/ccn2/), [CCND1](https://onco.cc/targets/ccnd1/), [CCND2](https://onco.cc/targets/ccnd2/), [CCND3](https://onco.cc/targets/ccnd3/), [CCNE1](https://onco.cc/targets/ccne1/), [CCNE2](https://onco.cc/targets/ccne2/), [CD44](https://onco.cc/targets/cd44/), [CD58](https://onco.cc/targets/cd58/), [CD83](https://onco.cc/targets/cd83/), [CDC50A](https://onco.cc/targets/cdc50a/), [CDH1](https://onco.cc/targets/cdh1/), [CDK12](https://onco.cc/targets/cdk12/), [CDK2](https://onco.cc/targets/cdk2/), [CDK5](https://onco.cc/targets/cdk5/), [CDK9](https://onco.cc/targets/cdk9/), [CDKN1A](https://onco.cc/targets/cdkn1a/), [CDKN1B](https://onco.cc/targets/cdkn1b/), [CDKN2A](https://onco.cc/targets/cdkn2a/), [CDKN2B](https://onco.cc/targets/cdkn2b/), [CDX2](https://onco.cc/targets/cdx2/), [CEACAM1](https://onco.cc/targets/ceacam1/), [CEBPA](https://onco.cc/targets/cebpa/), [CFLAR](https://onco.cc/targets/cflar/), [CHD8](https://onco.cc/targets/chd8/), [CHEK1](https://onco.cc/targets/chek1/), [CHEK2](https://onco.cc/targets/chek2/), [CIC](https://onco.cc/targets/cic/), [CIITA](https://onco.cc/targets/ciita/), [CIP2A](https://onco.cc/targets/cip2a/), [CREBBP](https://onco.cc/targets/crebbp/), [CRKL](https://onco.cc/targets/crkl/), [CRLF2](https://onco.cc/targets/crlf2/), [CSF1](https://onco.cc/targets/csf1/), [CSF2RB](https://onco.cc/targets/csf2rb/), [CTAG1B](https://onco.cc/targets/ctag1b/), [CTAG2](https://onco.cc/targets/ctag2/), [CTCF](https://onco.cc/targets/ctcf/), [CTNNB1](https://onco.cc/targets/ctnnb1/), [CUL3](https://onco.cc/targets/cul3/), [CUL7](https://onco.cc/targets/cul7/), [CX3CL1](https://onco.cc/targets/cx3cl1/), [CXCL10](https://onco.cc/targets/cxcl10/), [CYP2D6](https://onco.cc/targets/cyp2d6/), [CYSLTR2](https://onco.cc/targets/cysltr2/), [DAZAP1](https://onco.cc/targets/dazap1/), [DCC](https://onco.cc/targets/dcc/), [DDX3X](https://onco.cc/targets/ddx3x/), [DDX41](https://onco.cc/targets/ddx41/), [DDX43](https://onco.cc/targets/ddx43/), [DEFA1](https://onco.cc/targets/defa1/), [DICER1](https://onco.cc/targets/dicer1/), [DKK1](https://onco.cc/targets/dkk1/), [DPYD](https://onco.cc/targets/dpyd/), [DRD5](https://onco.cc/targets/drd5/), [DROSHA](https://onco.cc/targets/drosha/), [DTX1](https://onco.cc/targets/dtx1/), [DUSP2](https://onco.cc/targets/dusp2/), [DUSP6](https://onco.cc/targets/dusp6/), [EBF1](https://onco.cc/targets/ebf1/), [ECSCR](https://onco.cc/targets/ecscr/), [EGF](https://onco.cc/targets/egf/), [EIF1AX](https://onco.cc/targets/eif1ax/), [EIF4A1](https://onco.cc/targets/eif4a1/), [EIF4EBP1](https://onco.cc/targets/eif4ebp1/), [EMSY](https://onco.cc/targets/emsy/), [EP300](https://onco.cc/targets/ep300/), [EPHB2](https://onco.cc/targets/ephb2/), [EPHB4](https://onco.cc/targets/ephb4/), [ERCC1](https://onco.cc/targets/ercc1/), [ERCC2](https://onco.cc/targets/ercc2/), [ERCC3](https://onco.cc/targets/ercc3/), [ERCC4](https://onco.cc/targets/ercc4/), [ERCC5](https://onco.cc/targets/ercc5/), [ERCC6](https://onco.cc/targets/ercc6/), [EREG](https://onco.cc/targets/ereg/), [ERG](https://onco.cc/targets/erg/), [ERRFI1](https://onco.cc/targets/errfi1/), [ESR2](https://onco.cc/targets/esr2/), [ETS1](https://onco.cc/targets/ets1/), [ETS2](https://onco.cc/targets/ets2/), [ETV1](https://onco.cc/targets/etv1/), [ETV4](https://onco.cc/targets/etv4/), [ETV5](https://onco.cc/targets/etv5/), [ETV6](https://onco.cc/targets/etv6/), [FAAP20](https://onco.cc/targets/faap20/), [FANCA](https://onco.cc/targets/fanca/), [FANCC](https://onco.cc/targets/fancc/), [FANCL](https://onco.cc/targets/fancl/), [FAS](https://onco.cc/targets/fas/), [FAT1](https://onco.cc/targets/fat1/), [FBXO11](https://onco.cc/targets/fbxo11/), [FBXW11](https://onco.cc/targets/fbxw11/), [FBXW7](https://onco.cc/targets/fbxw7/), [FCGR2A](https://onco.cc/targets/fcgr2a/), [FCGR2B](https://onco.cc/targets/fcgr2b/), [FCGR3A](https://onco.cc/targets/fcgr3a/), [FGF13](https://onco.cc/targets/fgf13/), [FGF19](https://onco.cc/targets/fgf19/), [FGF2](https://onco.cc/targets/fgf2/), [FGF3](https://onco.cc/targets/fgf3/), [FGF4](https://onco.cc/targets/fgf4/), [FGFR4](https://onco.cc/targets/fgfr4/), [FH](https://onco.cc/targets/fh/), [FHIT](https://onco.cc/targets/fhit/), [FLCN](https://onco.cc/targets/flcn/), [FLT3LG](https://onco.cc/targets/flt3lg/), [FN1](https://onco.cc/targets/fn1/), [FNTB](https://onco.cc/targets/fntb/), [FOS](https://onco.cc/targets/fos/), [FOSB](https://onco.cc/targets/fosb/), [FOXA1](https://onco.cc/targets/foxa1/), [FOXC2](https://onco.cc/targets/foxc2/), [FOXF1](https://onco.cc/targets/foxf1/), [FOXL2](https://onco.cc/targets/foxl2/), [FOXO1](https://onco.cc/targets/foxo1/), [FOXP1](https://onco.cc/targets/foxp1/), [FOXP3](https://onco.cc/targets/foxp3/), [FOXR2](https://onco.cc/targets/foxr2/), [FUBP1](https://onco.cc/targets/fubp1/), [GADD45A](https://onco.cc/targets/gadd45a/), [GALNT14](https://onco.cc/targets/galnt14/), [GAS6](https://onco.cc/targets/gas6/), [GATA1](https://onco.cc/targets/gata1/), [GATA2](https://onco.cc/targets/gata2/), [GATA3](https://onco.cc/targets/gata3/), [GNA11](https://onco.cc/targets/gna11/), [GNA13](https://onco.cc/targets/gna13/), [GNAI2](https://onco.cc/targets/gnai2/), [GNAQ](https://onco.cc/targets/gnaq/), [GNAS](https://onco.cc/targets/gnas/), [GRHPR](https://onco.cc/targets/grhpr/), [GSTP1](https://onco.cc/targets/gstp1/), [H1-2](https://onco.cc/targets/h1-2/), [H1-3](https://onco.cc/targets/h1-3/), [H1-5](https://onco.cc/targets/h1-5/), [H2AC17](https://onco.cc/targets/h2ac17/), [H2AC6](https://onco.cc/targets/h2ac6/), [H2BC12](https://onco.cc/targets/h2bc12/), [H2BC5](https://onco.cc/targets/h2bc5/), [H3-3B](https://onco.cc/targets/h3-3b/), [H3C14](https://onco.cc/targets/h3c14/), [H3C2](https://onco.cc/targets/h3c2/), [H3C4](https://onco.cc/targets/h3c4/), [HBB](https://onco.cc/targets/hbb/), [HDAC9](https://onco.cc/targets/hdac9/), [HGF](https://onco.cc/targets/hgf/), [Histone H3.3 (H3-3A)](https://onco.cc/targets/h3-3a/), [HLA-B](https://onco.cc/targets/hla-b/), [HLA-C](https://onco.cc/targets/hla-c/), [HLA-DRA](https://onco.cc/targets/hla-dra/), [HMOX1](https://onco.cc/targets/hmox1/), [HNRNPH1](https://onco.cc/targets/hnrnph1/), [HNRNPU](https://onco.cc/targets/hnrnpu/), [HOXB13](https://onco.cc/targets/hoxb13/), [HOXC10](https://onco.cc/targets/hoxc10/), [HOXD8](https://onco.cc/targets/hoxd8/), [HRAS](https://onco.cc/targets/hras/), [HSP90B1](https://onco.cc/targets/hsp90b1/), [HSPA5](https://onco.cc/targets/hspa5/), [HSPB1](https://onco.cc/targets/hspb1/), [HSPH1](https://onco.cc/targets/hsph1/), [HVCN1](https://onco.cc/targets/hvcn1/), [ID3](https://onco.cc/targets/id3/), [IFNGR1](https://onco.cc/targets/ifngr1/), [IGF2](https://onco.cc/targets/igf2/), [IL33](https://onco.cc/targets/il33/), [IL4R](https://onco.cc/targets/il4r/), [IL7R](https://onco.cc/targets/il7r/), [IRF8](https://onco.cc/targets/irf8/), [IRS2](https://onco.cc/targets/irs2/), [ITPKB](https://onco.cc/targets/itpkb/), [JAK3](https://onco.cc/targets/jak3/), [JUN](https://onco.cc/targets/jun/), [KDM5C](https://onco.cc/targets/kdm5c/), [KDM5D](https://onco.cc/targets/kdm5d/), [KDM6A](https://onco.cc/targets/kdm6a/), [KEAP1](https://onco.cc/targets/keap1/), [Ki-67 (MKI67)](https://onco.cc/targets/mki67/), [KIF23](https://onco.cc/targets/kif23/), [KLF2](https://onco.cc/targets/klf2/), [KLF4](https://onco.cc/targets/klf4/), [KLF5](https://onco.cc/targets/klf5/), [KLHL14](https://onco.cc/targets/klhl14/), [KLHL6](https://onco.cc/targets/klhl6/), [KLLN](https://onco.cc/targets/klln/), [KMT2B](https://onco.cc/targets/kmt2b/), [KMT2C](https://onco.cc/targets/kmt2c/), [KMT2D](https://onco.cc/targets/kmt2d/), [KRT18](https://onco.cc/targets/krt18/), [LEPR](https://onco.cc/targets/lepr/), [LGR5](https://onco.cc/targets/lgr5-gene/), [LRP1B](https://onco.cc/targets/lrp1b/), [LTB](https://onco.cc/targets/ltb/), [LZTR1](https://onco.cc/targets/lztr1/), [MAGEH1](https://onco.cc/targets/mageh1/), [MAP2K4](https://onco.cc/targets/map2k4/), [MAP2K7](https://onco.cc/targets/map2k7/), [MAP3K1](https://onco.cc/targets/map3k1/), [MAPK1](https://onco.cc/targets/mapk1/), [MBD4](https://onco.cc/targets/mbd4/), [MCL1](https://onco.cc/targets/mcl1/), [MDM4](https://onco.cc/targets/mdm4/), [MECOM](https://onco.cc/targets/mecom/), [MEF2B](https://onco.cc/targets/mef2b/), [MEF2C](https://onco.cc/targets/mef2c/), [MEF2D](https://onco.cc/targets/mef2d/), [MERTK](https://onco.cc/targets/mertk/), [MGA](https://onco.cc/targets/mga/), [MGMT (O6-methylguanine-DNA methyltransferase)](https://onco.cc/targets/mgmt-protein/), [MIR21](https://onco.cc/targets/mir21/), [MIR218-1](https://onco.cc/targets/mir218-1/), [MITF](https://onco.cc/targets/mitf/), [MLH1](https://onco.cc/targets/mlh1/), [MMP1](https://onco.cc/targets/mmp1/), [MMP2](https://onco.cc/targets/mmp2/), [MMP9](https://onco.cc/targets/mmp9/), [MN1](https://onco.cc/targets/mn1/), [MPEG1](https://onco.cc/targets/mpeg1/), [MRE11](https://onco.cc/targets/mre11/), [MSH2](https://onco.cc/targets/msh2/), [MSH3](https://onco.cc/targets/msh3/), [MSH6](https://onco.cc/targets/msh6/), [MTHFR](https://onco.cc/targets/mthfr/), [MUS81](https://onco.cc/targets/mus81/), [MYB](https://onco.cc/targets/myb/), [MYBL1](https://onco.cc/targets/mybl1/), [MYC](https://onco.cc/targets/myc-gene/), [MYCL](https://onco.cc/targets/mycl/), [MYCN (N-myc)](https://onco.cc/targets/mycn/), [MYD88](https://onco.cc/targets/myd88/), [MYOD1](https://onco.cc/targets/myod1/), [NAPRT](https://onco.cc/targets/naprt/), [NBN](https://onco.cc/targets/nbn/), [NCOA3](https://onco.cc/targets/ncoa3/), [NEDD9](https://onco.cc/targets/nedd9/), [NF2](https://onco.cc/targets/nf2/), [NFE2L2](https://onco.cc/targets/nfe2l2/), [NFKBIA](https://onco.cc/targets/nfkbia/), [NFKBIE](https://onco.cc/targets/nfkbie/), [NFKBIZ](https://onco.cc/targets/nfkbiz/), [NOL9](https://onco.cc/targets/nol9/), [NOTCH1](https://onco.cc/targets/notch1/), [NOTCH2](https://onco.cc/targets/notch2/), [NOTCH3](https://onco.cc/targets/notch3/), [NPTXR](https://onco.cc/targets/nptxr/), [NQO1](https://onco.cc/targets/nqo1/), [NR2F2](https://onco.cc/targets/nr2f2/), [NR4A2](https://onco.cc/targets/nr4a2/), [NR4A3](https://onco.cc/targets/nr4a3/), [NRG1](https://onco.cc/targets/nrg1/), [NSD2](https://onco.cc/targets/nsd2/), [NT5C2](https://onco.cc/targets/nt5c2/), [NUDT15](https://onco.cc/targets/nudt15/), [ORC1](https://onco.cc/targets/orc1/), [OSBPL10](https://onco.cc/targets/osbpl10/), [OVOL2](https://onco.cc/targets/ovol2/), [P2RY8](https://onco.cc/targets/p2ry8/), [PALB2](https://onco.cc/targets/palb2/), [PAPPA2](https://onco.cc/targets/pappa2/), [PAX5](https://onco.cc/targets/pax5/), [PAX8](https://onco.cc/targets/pax8/), [PBK](https://onco.cc/targets/pbk/), [PBLD](https://onco.cc/targets/pbld/), [PBRM1](https://onco.cc/targets/pbrm1/), [PCBP1](https://onco.cc/targets/pcbp1/), [PCNA](https://onco.cc/targets/pcna/), [PDCD1LG2](https://onco.cc/targets/pdcd1lg2/), [PDCD4](https://onco.cc/targets/pdcd4/), [PDGFB](https://onco.cc/targets/pdgfb/), [PIK3CB](https://onco.cc/targets/pik3cb/), [PIK3R1](https://onco.cc/targets/pik3r1/), [PIK3R2](https://onco.cc/targets/pik3r2/), [PIM1](https://onco.cc/targets/pim1/), [PIM2](https://onco.cc/targets/pim2/), [PLCG1](https://onco.cc/targets/plcg1/), [PLCG2](https://onco.cc/targets/plcg2/), [PLK1](https://onco.cc/targets/plk1/), [PML](https://onco.cc/targets/pml/), [PMS2](https://onco.cc/targets/pms2/), [POLD1](https://onco.cc/targets/pold1/), [POLE](https://onco.cc/targets/pole/), [POLE4](https://onco.cc/targets/pole4/), [POT1](https://onco.cc/targets/pot1/), [POU2AF1](https://onco.cc/targets/pou2af1/), [POU2F2](https://onco.cc/targets/pou2f2/), [POU5F1](https://onco.cc/targets/pou5f1/), [PPP1R15A](https://onco.cc/targets/ppp1r15a/), [PPP2R1A](https://onco.cc/targets/ppp2r1a/), [PPP2R2A](https://onco.cc/targets/ppp2r2a/), [PRDM1](https://onco.cc/targets/prdm1/), [PREX2](https://onco.cc/targets/prex2/), [PRKAA2](https://onco.cc/targets/prkaa2/), [PRKAR1A](https://onco.cc/targets/prkar1a/), [PRKCB](https://onco.cc/targets/prkcb/), [PRKDC](https://onco.cc/targets/prkdc/), [PRKN](https://onco.cc/targets/prkn/), [PRNCR1](https://onco.cc/targets/prncr1/), [PROM1](https://onco.cc/targets/prom1/), [PRPS1](https://onco.cc/targets/prps1/), [PSMB8](https://onco.cc/targets/psmb8/), [PSMD4](https://onco.cc/targets/psmd4/), [PTEN](https://onco.cc/targets/pten/), [PTP4A3](https://onco.cc/targets/ptp4a3/), [PTPN12](https://onco.cc/targets/ptpn12/), [PTPN6](https://onco.cc/targets/ptpn6/), [PTPRB](https://onco.cc/targets/ptprb/), [PTPRD](https://onco.cc/targets/ptprd/), [PTPRF](https://onco.cc/targets/ptprf/), [PTPRT](https://onco.cc/targets/ptprt/), [PTTG1](https://onco.cc/targets/pttg1/), [PXDNL](https://onco.cc/targets/pxdnl/), [RABL3](https://onco.cc/targets/rabl3/), [RAC1](https://onco.cc/targets/rac1/), [RAD23B](https://onco.cc/targets/rad23b/), [RAD50](https://onco.cc/targets/rad50/), [RAD51B](https://onco.cc/targets/rad51b/), [RAD51C](https://onco.cc/targets/rad51c/), [RAD51D](https://onco.cc/targets/rad51d/), [RAD54L](https://onco.cc/targets/rad54l/), [RASA1](https://onco.cc/targets/rasa1/), [RB1](https://onco.cc/targets/rb1/), [REL](https://onco.cc/targets/rel/), [RFX7](https://onco.cc/targets/rfx7/), [RHEB](https://onco.cc/targets/rheb/), [RHOA](https://onco.cc/targets/rhoa/), [RICTOR](https://onco.cc/targets/rictor/), [RIT1](https://onco.cc/targets/rit1/), [ROBO4](https://onco.cc/targets/robo4/), [RPS6](https://onco.cc/targets/rps6/), [RRAS2](https://onco.cc/targets/rras2/), [RRM2](https://onco.cc/targets/rrm2/), [RSF1](https://onco.cc/targets/rsf1/), [RUNX1](https://onco.cc/targets/runx1/), [S100B](https://onco.cc/targets/s100b/), [S1PR1](https://onco.cc/targets/s1pr1/), [S1PR2](https://onco.cc/targets/s1pr2/), [SCN8A](https://onco.cc/targets/scn8a/), [SDHA](https://onco.cc/targets/sdha/), [SDHB](https://onco.cc/targets/sdhb/), [SETBP1](https://onco.cc/targets/setbp1/), [SETD1B](https://onco.cc/targets/setd1b/), [SETD2](https://onco.cc/targets/setd2/), [SF3B1](https://onco.cc/targets/sf3b1/), [SGK1](https://onco.cc/targets/sgk1/), [SH2B3](https://onco.cc/targets/sh2b3/), [SIN3A](https://onco.cc/targets/sin3a/), [SIRT1](https://onco.cc/targets/sirt1/), [SLC12A2](https://onco.cc/targets/slc12a2/), [SLC29A1](https://onco.cc/targets/slc29a1/), [SLCO1B1](https://onco.cc/targets/slco1b1/), [SLFN11](https://onco.cc/targets/slfn11/), [SMAD2](https://onco.cc/targets/smad2/), [SMAD3](https://onco.cc/targets/smad3/), [SMAD4](https://onco.cc/targets/smad4/), [SMARCA2](https://onco.cc/targets/smarca2/), [SMARCA4](https://onco.cc/targets/smarca4/), [SMARCB1](https://onco.cc/targets/smarcb1/), [SNCAIP](https://onco.cc/targets/sncaip/), [SOCS1](https://onco.cc/targets/socs1/), [SOS1](https://onco.cc/targets/sos1/), [SOX10](https://onco.cc/targets/sox10/), [SP140](https://onco.cc/targets/sp140/), [SPEN](https://onco.cc/targets/spen/), [SPHK1](https://onco.cc/targets/sphk1/), [SPOP](https://onco.cc/targets/spop/), [SPRY2](https://onco.cc/targets/spry2/), [SRSF2](https://onco.cc/targets/srsf2/), [SSTR5](https://onco.cc/targets/sstr5/), [STAG2](https://onco.cc/targets/stag2/), [STAG2-AS1](https://onco.cc/targets/stag2-as1/), [STAG3](https://onco.cc/targets/stag3/), [STAT1](https://onco.cc/targets/stat1/), [STAT3](https://onco.cc/targets/stat3/), [STAT6](https://onco.cc/targets/stat6/), [STK11](https://onco.cc/targets/stk11/), [STMN1](https://onco.cc/targets/stmn1/), [SUFU](https://onco.cc/targets/sufu/), [SYK](https://onco.cc/targets/syk/), [TBK1](https://onco.cc/targets/tbk1/), [TBL1XR1](https://onco.cc/targets/tbl1xr1/), [TBXT](https://onco.cc/targets/tbxt/), [TCF19](https://onco.cc/targets/tcf19/), [TCF3](https://onco.cc/targets/tcf3/), [TERT](https://onco.cc/targets/tert/), [TET1](https://onco.cc/targets/tet1/), [TF](https://onco.cc/targets/tf/), [TFAP4](https://onco.cc/targets/tfap4/), [TFEB](https://onco.cc/targets/tfeb/), [TFF3](https://onco.cc/targets/tff3/), [TGFA](https://onco.cc/targets/tgfa/), [TGFBR3](https://onco.cc/targets/tgfbr3/), [THBS2](https://onco.cc/targets/thbs2/), [TIMP1](https://onco.cc/targets/timp1/), [TLK2](https://onco.cc/targets/tlk2/), [TMSB4X](https://onco.cc/targets/tmsb4x/), [TNC](https://onco.cc/targets/tnc/), [TNFAIP3](https://onco.cc/targets/tnfaip3/), [TNFRSF14](https://onco.cc/targets/tnfrsf14/), [TOX](https://onco.cc/targets/tox/), [TP53BP1](https://onco.cc/targets/tp53bp1/), [TPT1](https://onco.cc/targets/tpt1/), [TSC1](https://onco.cc/targets/tsc1/), [TSC2](https://onco.cc/targets/tsc2/), [TSPYL1](https://onco.cc/targets/tspyl1/), [TTF1](https://onco.cc/targets/ttf1/), [TUBB3](https://onco.cc/targets/tubb3/), [TYK2](https://onco.cc/targets/tyk2/), [U2AF1](https://onco.cc/targets/u2af1/), [UBE2A](https://onco.cc/targets/ube2a/), [UBR5](https://onco.cc/targets/ubr5/), [UBTF](https://onco.cc/targets/ubtf/), [UGT1A](https://onco.cc/targets/ugt1a/), [UGT1A1](https://onco.cc/targets/ugt1a1/), [USP7](https://onco.cc/targets/usp7/), [VEGFC](https://onco.cc/targets/vegfc/), [VHL](https://onco.cc/targets/vhl/), [VPS37A](https://onco.cc/targets/vps37a/), [WDR12](https://onco.cc/targets/wdr12/), [WNK1](https://onco.cc/targets/wnk1/), [WNT11](https://onco.cc/targets/wnt11/), [WNT6](https://onco.cc/targets/wnt6/), [WT1](https://onco.cc/targets/wt1/), [XRCC1](https://onco.cc/targets/xrcc1/), [XRCC3](https://onco.cc/targets/xrcc3/), [YAP1](https://onco.cc/targets/yap1/), [YES1](https://onco.cc/targets/yes1/), [ZEB1](https://onco.cc/targets/zeb1/), [ZFP36L1](https://onco.cc/targets/zfp36l1/), [ZHX2](https://onco.cc/targets/zhx2/), [ZNF217](https://onco.cc/targets/znf217/), [ZNF292](https://onco.cc/targets/znf292/), [ZNF703](https://onco.cc/targets/znf703/), [ZRSR2](https://onco.cc/targets/zrsr2/)
- institutions: [Siteman Cancer Center, Washington University](https://onco.cc/institutions/wustl-siteman/)
- collections: [awesome-cancer-variant-resources](https://onco.cc/collections/awesome-cancer-variant-resources/), [IntOGen](https://onco.cc/collections/intogen/)
- bottlenecks: [Knowledge reaches practice too slowly](https://onco.cc/bottlenecks/b-knowledge-diffusion/)
- ideas: [An open knowledge graph linking trials, results, biomarkers, drugs and recommendations](https://onco.cc/ideas/idea-data-open-evidence-knowledge-graph/), [Every tumour genomic report machine-readable and deposited nationally](https://onco.cc/ideas/idea-data-structured-genomic-reports/), [Every tumour sequencing report lists open, nearby, matched trials pulled live](https://onco.cc/ideas/idea-tr1-ngs-report-live-trial-match/), [Label every biomarker claim with an evidence phase, like drugs](https://onco.cc/ideas/idea-tr2-biomarker-evidence-grading/)
- terms: [Actionable genomic biomarkers](https://onco.cc/terms/cancer-drivers-vs-actionable/), [HGVS variant nomenclature](https://onco.cc/terms/hgvs/)

---
JSON: https://onco.cc/api/v1/entities/civic.json